Progress of Endogenous and Exogenous Nanoparticles for Cancer Therapy and Diagnostics
Genes · 2023
DOI: 10.3390/genes14020259 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, 2023. Verfasst von Hideaki Fujita und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Minami-ku, Hiroshima 734-8553, Ja…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JST PRESTO, JSPS KAKENHI, AMED.
Abstract (Originalsprache)
The focus of this brief review is to describe the application of nanoparticles, including endogenous nanoparticles (e.g., extracellular vesicles, EVs, and virus capsids) and exogenous nanoparticles (e.g., organic and inorganic materials) in cancer therapy and diagnostics. In this review, we mainly focused on EVs, where a recent study demonstrated that EVs secreted from cancer cells are associated with malignant alterations in cancer. EVs are expected to be used for cancer diagnostics by analyzing their informative cargo. Exogenous nanoparticles are also used in cancer diagnostics as imaging probes because they can be easily functionalized. Nanoparticles are promising targets for drug delivery system (DDS) development and have recently been actively studied. In this review, we introduce nanoparticles as a powerful tool in the field of cancer therapy and diagnostics and discuss issues and future prospects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Stem Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Minami-ku, Hiroshima 734-8553, Japan.
- Institute of Engineering Innovation, The University of Tokyo, 7-3-1 Hongo, Bunkyo ku, Tokyo 113-8656, Japan.
- Precursor Research for Embryonic Science (PRESTO), Japan Science and Technology Agency (JST), 4-1-8, Honcho, Kawaguchi-shi, Saitama 332-0012, Japan.
- SANKEN (The Institute of Scientific and Industrial Research), Osaka University, 8-1 Mihogaoka, Osaka 567-0047, Japan.
- Division of Biochemical Engineering, Radioisotope Research Center, Kyoto University, Yoshida-Konoe-Cho, Sakyo-ku, Kyoto 606-8507, Japan.
ORCID-Profile: Hideaki Fujita, Noriko Nakamura, Masaharu Somiya, Masanobu Horie
Förderung
- JST PRESTO
- JSPS KAKENHI
- AMED
- Takeda Science Foundation
Zitieren
APA
Fujita, H., Ohta, S., Nakamura, N., Somiya, M., & Horie, M. (2023). Progress of Endogenous and Exogenous Nanoparticles for Cancer Therapy and Diagnostics. Genes. https://doi.org/10.3390/genes14020259
Vancouver
Fujita H, Ohta S, Nakamura N, Somiya M, Horie M. Progress of Endogenous and Exogenous Nanoparticles for Cancer Therapy and Diagnostics. Genes. 2023. doi:10.3390/genes14020259
BibTeX
@article{Fujita2023,
author = {Fujita, Hideaki and Ohta, Seiichi and Nakamura, Noriko and Somiya, Masaharu and Horie, Masanobu},
title = {Progress of Endogenous and Exogenous Nanoparticles for Cancer Therapy and Diagnostics},
journal = {Genes},
year = {2023},
doi = {10.3390/genes14020259}
}
EUVIMED